| Differential effects of 2C9* 3 and 2C9* 2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol J Hermida, J Zarza, I Alberca, R Montes, ML López, E Molina, E Rocha Blood, The Journal of the American Society of Hematology 99 (11), 4237-4239, 2002 | 134 | 2002 |
| VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A R Catena, L Larzabal, M Larrayoz, E Molina, J Hermida, J Agorreta, ... Molecular Cancer 9, 1-14, 2010 | 103 | 2010 |
| Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma I Antón, E Molina, D Luis-Ravelo, C Zandueta, K Valencia, C Ormazabal, ... American journal of respiratory and critical care medicine 186 (1), 96-105, 2012 | 62 | 2012 |
| Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma I Antón, E Molina, D Luis-Ravelo, C Zandueta, K Valencia, C Ormazabal, ... American journal of respiratory and critical care medicine 186 (1), 96-105, 2012 | 62 | 2012 |
| Short leukocyte telomere length is associated with cardioembolic stroke risk in patients with atrial fibrillation M Allende, E Molina, JR González-Porras, E Toledo, R Lecumberri, ... Stroke 47 (3), 863-865, 2016 | 36 | 2016 |
| Is EPCR a multi-ligand receptor? Pros and cons R Montes, C Puy, E Molina, J Hermida Thrombosis and haemostasis 107 (05), 815-826, 2012 | 36 | 2012 |
| Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk M Allende, E Molina, E Guruceaga, I Tamayo, JR González-Porras, ... Cardiovascular research 110 (3), 309-318, 2016 | 35 | 2016 |
| The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing E Molina, J Hermida, J López-Sagaseta, C Puy, R Montes Ferrata Storti Foundation, 2008 | 14* | 2008 |
| The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing E Molina, J Hermida, J López-Sagaseta, C Puy, R Montes Ferrata Storti Foundation, 2008 | 11 | 2008 |
| Inducing heat shock protein 70 expression provides a robust anti-thrombotic effect with minimal bleeding risk M Allende, E Molina, R Lecumberri, JA Sánchez-Arias, A Ugarte, ... Thrombosis and Haemostasis 117 (09), 1722-1729, 2017 | 10 | 2017 |
| Predisposición genética al sangrado durante el tratamiento con anticoagulantes orales R Montes, O Nantes, E Molina, J Zozaya, J Hermida Anales del Sistema Sanitario de Navarra 31 (3), 247-257, 2008 | 6 | 2008 |
| Direct Oral Anticoagulants in Pre-Heart Transplant Patients: A Promising Approach J Conway, R Loungani, A Robbins, M Griffith, E Molina The Journal of Heart and Lung Transplantation 43 (4), S359-S360, 2024 | | 2024 |
| THE INDUCTION OF HSP70 BY A NEW SMALL MOLECULA (CM-695) HAS AN ANTITROMBOTIC EFFECT AS EFFECTIVE AS RIVAROXABAN BUT WITHOUT HEMORRHAGIC EFFECT M Allende, E Molina, R Lecumberri, J Sanchez Arias, A Ugarte, ... HAEMATOLOGICA 102, 5-6, 2017 | | 2017 |
| F Lung Cancer and Oncologic Disorders-Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma I Antón, E Molina, D Luis-Ravelo, C Zandueta, K Valencia, C Ormazabal, ... American Journal of Respiratory and CriticalCare Medicine 186 (1), 96, 2012 | | 2012 |
| Genetic predisposition to bleeding during oral anticoagulants treatment O Nantes, E Molina, J Zozaya, J Hermida Anales del Sistema Sanitario de Navarra 31 (3), 247-257, 2008 | | 2008 |
| Genetic predisposition to bleeding during oral anticoagulants treatment R Montes, O Nantes, E Molina, JM Zozaya, J Hermida Gobierno de Navarra. Departamento de Salud, 2008 | | 2008 |
| Predisposición genética al sangrado durante el tratamiento RM Díaz, O Nantes, E Molina, J Zozaya, J Hermida Anales del Sistema Sanitario de Navarra 31 (3), 247-258, 2008 | | 2008 |
